Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation

A high proportion of patients with irritable bowel syndrome (IBS) respond to placebo in clinical trials (estimated at about 40%). We aimed to identify factors that contribute to the high placebo response rate using data from a placebo-controlled trials of patients with IBS.

https://ift.tt/2GU5F54